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Abstract
Cyclin A1 (Ccna1), a member of the mammalian A type cyclins, is most abundantly
expressed in spermatocytes and is essential for spermatogenesis in the mouse. Ccna1-
deficient spermatocytes arrest at late meiotic prophase and undergo apoptosis. To further
delineate the mechanisms and key factors involved in this process, we have examined
changes in expression of genes involved in both intrinsic and extrinsic signaling pathways
that trigger apoptosis in the mutant spermatocytes. Our results show that both pathways are
involved, and that the factors involved in the intrinsic pathway were expressed earlier than
those involved in the extrinsic pathway. We have also begun to identify in vivo Ccna1-
interacting proteins, using an unbiased biochemical approach, and identified 14-3-3, a key
regulator of apoptosis, as a Ccna1-interacting protein. Expression levels of 14-3-3 proteins
remain unchanged between wild type and mutant testes but there were differences in the
subcellular distribution. In wild type control, 14-3-3 is detected in both cytosolic and nuclear
fractions whereas it is restricted to the cytoplasm in mutant testes. This differential distribu-
tion of 14-3-3 may contribute to the induction of apoptosis in Ccna1-deficient spermatocytes.
These results provide insight into the apoptotic mechanisms and pathways that are trig-
gered when progression through the meiotic cell cycle is defective in male gametogenesis.
Introduction
Apoptosis is an evolutionarily conserved mechanism of programed cell death that occurs in
response to certain physiological stimuli, cell injury, or stress, and is a vital component of vari-
ous developmental processes in metazoans [1, 2]. In the mammalian testis, apoptosis plays a
major role in regulating spermatogenesis [3] and in ensuring the genetic quality of the gamete
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[4]. In juvenile mouse testes, massive apoptosis occurs during the first wave of spermatogenesis
to regulate the number of germ cells and their ratio relative to the number of Sertoli cells [5].
During meiosis, apoptosis is triggered when defects in complex processes such as synapsis,
recombination, and segregation of homologues compromise the quality of the spermatocyte
[6]. Indeed, the normal occurrence of these processes is strictly regulated by meiotic check-
points that create a network of signaling mechanisms that modulates the activity and progres-
sion of meiosis. Depletion of essential survival factors and persistent meiotic defects are sensed
by these highly conserved meiotic checkpoints, which then cause an arrest of cellular progres-
sion of the defective cells and an induction of the apoptotic program [7].
The regulation of apoptosis in the various spermatogenic cells involves both an extrinsic
apoptotic pathway (cell surface death receptor-mediated) involving the Fas/FasL proteins and
caspases 8 and/or 10 [3] as well as an intrinsic pathway (mitochondria-mediated) through the
Bax/Bcl-2 family proteins and caspase 9 [8]. In meiosis, apoptosis is generally triggered by a
CHK2-dependent activation of the p53 family proteins in specific sub-stages of prophase I [9].
There is an interesting sexual dichotomy in terms of how stringently apoptosis is induced dur-
ing meiosis. That is, during oogenesis, not all meiotic defects drive cells to undergo apoptosis,
making oocytes more susceptible to completing meiosis carrying chromosome defects [10].
When apoptosis does occur, both intrinsic and extrinsic pathways are involved in the death of
the oocytes at various stages of meiotic prophase [11]. In contrast, spermatocytes with meiotic
defects usually undergo apoptosis during pachynema, the transition of prophase I to meta-
phase I, and/or metaphase I [12]. Despite significant progress in the understanding of the mei-
otic checkpoints, little is known about the apoptotic mechanisms and pathways that are
triggered when meiosis is defective in male gametogenesis.
We have shown by targeted mutagenesis that the male germ cell specific A-type cyclin,
cyclin A1 (Ccna1), is an essential regulator of the transition of spermatocytes from prophase I
to metaphase I [13]. Deficiency of Ccna1 resulted in a reduction of Cdk2 activation at the end
of meiotic prophase I, failure to progress into metaphase I, and induction of apoptosis in late
prophase spermatocytes [14, 15]. We have shown that this apoptosis is mediated by
p53-dependent and notably, also p53-independent pathways [15]. We also observed an activa-
tion of caspase-3 and an increase in the levels of and change of subcellular localization of the
apoptotic factor Bax [15].
In the present work, we extend these studies by showing that the apoptosis induced by the
depletion of Ccna1 in male meiosis involves changes in the ratio of apoptotic agonists and
antagonists in the defective spermatocytes. That is, loss of Ccna1 initiates apoptosis in sper-
matocytes both by up-regulating pro-apoptotic genes and down-regulating anti-apoptotic
genes. We show that these changes in gene expression appear to be meiotic-stage specific, as
that the intrinsic apoptotic pathway is triggered in mutant spermatocytes before the activation
of the extrinsic pathway. Notably, we also identify 14-3-3 proteins as novel Ccna1 interacting
partners and show that their subcellular distribution is altered in the absence of Ccna1. Our
results suggest that interaction of Ccna1 with 14-3-3 is important for meiotic progression as
well as inhibition of apoptosis in spermatocytes.
Materials and methods
Experimental animals
The Institutional Animal Care and Use Committee (IACUC) of Columbia University Medical
Center, New York, NY, USA approved all procedures involving animals. All animals were
housed in a pathogen free barrier facility and all manipulations were performed in accordance
with IACUC guidelines. Ccna1+/- males were mated with Ccna1-/- females to generate Ccna1-/-
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males and in parallel, Ccna1+/+ males and females of same genetic background were mated to
obtain Ccna1+/+ (referred as WT throughout) males for this study. Testes from Ccna1-/- and
the corresponding WT animals of postnatal day (PND) 17, 22 and 28 were used in the gene
expression and immunolocalization analyses. For pull-down and immunoprecipitation (IP)
experiments, WT mice of 8 weeks of age were used.
Sub-cellular fractionation and germ cell separation
The preparation of single cell suspensions from testes was performed according to our labora-
tory’s established protocol [16]. Total cell lysates from testicular suspensions were made as pre-
viously described [17]. Nuclear and cytoplasmic fractions from testicular cells were prepared
using the Active Motif nuclear extract kit (Active Motif Inc., #40010) according to the manu-
facturer’s protocol. Mitochondrial protein lysate was prepared by using the Thermo Scientific
mitochondria isolation kit (Thermo Scientific, #89874). Preparation of enriched populations
of pachytene spermatocytes was carried out according to our laboratory’s established protocol
[16]. The purity of cell populations was confirmed by flow-cytometry as described [18]. Pro-
tein concentrations in total testicular lysates, pachytene cell lysates and subcellular lysates were
determined by the Bradford assay (Bio-Rad., # 500–0006).
RNA purification and real-time PCR array
Preparation of testicular tubule suspensions from testes was carried out according to our
laboratory’s established protocol [16]. Total RNA was isolated from eighteen individual mouse
testes (three pairs of testes for age group and genotype as noted above) using RT qPCR-Grade
RNA Isolation Kit (Super Array Bioscience Corp., # PA001) as per the manufacturer’s proto-
col. Total RNA was rendered free of genomic DNA by on-column digestion with RNase-free
DNase1. Gene expression analysis for apoptotic pathways was performed using a real time-
PCR array (qRT-PCR) for mouse apoptosis (SuperArray Bioscience Corp., # PAMM012Z)
containing 84 apoptotis-related genes as described for mouse apoptosis in the RT2 Profiler
PCR Arrays list (http://www.sabiosciences.com/rt_pcr_product/HTML/PAMM-012Z.html,
Qiagen). qRT-PCR analysis of gene expression was carried out in an ABI 7300 gene expression
system (Applied Bio Systems). Real-time data were analyzed using the support system pro-
vided by the manufacturer and values plotted in Geom plot using R software. In brief, the
mean Ct value of three independent experiments was uploaded to the browser for each set of
experiments. Analysis was undertaken using the basic “set up” criteria and the quality was
reviewed by “Data QC” to ascertain the PCR reproducibility, reverse transcription efficiency,
and genomic DNA contamination. After passing the Data QC, each data set was normalized to
housekeeping genes already in the “set up”. The analyzed data provided the fold change or fold
regulation of the mutant group as compared to the control group for each set of experiments.
In our case it was for each age group; PND 17, PND 22 and PND 28 respectively.
Five genes identified in the array analysis were selected for confirmation and validation by
qRT-PCR. We picked at least two genes from each apoptotic pathway; either intrinsic or
extrinsic for further confirmation. In brief, 500ng of total RNA from each sample was reverse
transcribed using Superscript III first strand synthesis system (Invitrogen Inc. #18080–051)
with oligo dT primer in a 20μl reaction volume. Equal amounts of cDNA were subjected to
real-time PCR using SYBR-Green PCR master mix (Applied Bio systems) in an ABI 7300
qRT-PCR system. Primer pairs used in this study were as follows: Bcl2l10,5’- CCACTGCAT
GAACGCACTAGA-3’ (forward) and 5’-GAGCAACTTATCTGCCATCTCG-3’ (reverse);
Cradd, 5’-AAGGCGAGAGAGGAAGTCACA (forward) and 5’-GTTAATCTGCTGGTCT
GATGGC-3’ (reverse); Fas, 5’-TATCAAGGAGGCCCATTTTGC-3’ (forward) and 5’-
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TGTTTCCACTTCTAAACCATGCT-3’ (reverse); p21, 5’-CCTGGTGATGTCCGACCTG-3’
(forward) and 5’-CCATGAGCGCATCGCAATC-3’ (reverse); Sphk2, 5’-CACGGCGAGTT
TGGTTCCTA-3’ (forward) and 5’- CTTCTGGCTTTGGGCGTCGT-3’(reverse); Tnf, 5’-
TTGGTGGTTTGTGAGTGTGAG-3’ (forward) and 5’- GACGTGGAACTGGCAGAAGAG-3’
(reverse); and Arbp, 5’- CAAAGCTGAAGCAAAGGAAGAG-3’ (forward) and 5’-AATTAAG
CAGGCTGACTTGGTTG-3’ (reverse).
FLAG-Ccna1 pull down
FLAG peptide was fused to full-length Ccna1 cDNA sequence, inserted into the pFastBac1
donor plasmid (Invitrogen #10359–016), and then transformed to DH10Bac E. coli cells to
produce recombinant bacmid. Recombinant bacmid containing FLAG-Ccna1 was transfected
into sf9 cells using CELLFECTIN reagent (Invitrogen Inc., #10362). Recombinant baculovirus
particles were isolated and infected into fresh sf9 cells for protein expression. FLAG-Ccna1
was purified from 72 hrs post-infected cells using Anti-FLAG M2 agarose beads (Sigma
Aldrich, #2220) according to the manufacturer’s instructions. For the pull down experiment,
1mg of lysate from enriched pachytene cells was incubated with immobilized FLAG-Ccna1
overnight at 4˚C with rotation. A control experiment was performed in parallel, where equal
amount of lysates were incubated with immobilized FLAG peptide only. The immobilized
beads were washed three times with 1×TBST (0.9% NaCl, 0.1% Tween- 20, 100 mM Tris-HCl,
pH 7.5) and once with 1×TBS. Bound proteins were extracted by boiling the beads with 1×SDS
loading buffer for 5 minutes. Eluted proteins were subjected to SDS-PAGE for 15 minutes.
Once they entered into the resolving gel, the current was turned off. Gel bands (1cm2) were
cut and sent to the Columbia University protein core facility for mass spectrometry analysis
(LC-MS/MS). Raw data from mass spectrometry were acquired by Mass Lynx and then con-
verted to text files by using Protein Lynx software. A database search was performed using ref-
erence sequence databases from Mus musculus. Proteins/peptides were identified by using the
mascot algorithm at www.matrixscience.com.
Preparation of testes lysate, immunoprecipitation and immunoblotting
For immunoprecipitation and analysis, total lysates from whole testes of WT adult animals
were used. For, immunoblot analysis lysates were obtained from both WT and mutant testes.
Total testes lysates were prepared as described [17]. In brief, dissected and decapsulated testes
were homogenized immediately in RIPA buffer (50 mM Tris-Cl pH7.5, 150 mM NaCl, 0.1%
SDS, 0.5% Na deoxycholate, 1% NP-40 and protease inhibitor cocktail from Sigma) with a tis-
sue tearor (BioSpec Products Inc, Model #985370). Insoluble material was removed by centri-
fugation for 20 minutes at 12,000×g, at 4˚C. Protein concentration of the supernatants was
measured using the Bradford assay (Bio-Rad., # 500–0006). A total of 1mg of protein was used
for IP with antibodies against 14-3-3, Ccna1, or Rabbit IgG at 4˚C overnight. For direct immu-
noblot, the lysates (25μg/lane) were subjected to electrophoresis on SDS-polyacrylamide gels.
Proteins were transferred to polyvinylidene fluoride membranes blocked with 5% nonfat milk
in 1× TBST and incubated with primary antibodies overnight at 4˚C. Primary antibodies used
in this study are as follows: p21, Santa Cruz Biotechnology # sc-397; 14-3-3, Epitomics # 5175–
1; Caspase 8, Cell Signaling # 4927; Caspase 9, Cell Signaling # 9504; Caspase 10, Cell Signaling
# 9752; Bax, Santa Cruz Biotechnology # sc493; Bad, Santa Cruz Biotechnology # sc943; Phos-
pho-Akt, Cell Signaling # 4060; Akt, Cell Signaling # 2920; and Ccna1 (generated by our lab).
After three washes with TBST, the membranes were incubated with horseradish peroxidase
(HRP) conjugated rabbit/mouse secondary antibodies (Santa Cruz Biotechnology # sc2004
and # sc2005) for 1 hour. After three additional washes with 1× TBST, HRP activity was
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visualized with the Millipore Immobilon Western Blotting Detection kit (Millipore,
#WBKLS0500) according to the manufacturer’s instructions. Band intensity was quantified
using image J software and normalized with loading controls.
Immunofluorescence
Testes from 17 day-old WT and Ccna1-/- mice were embedded in OCT, after fixation with 4%
paraformaldehyde (PFA) and cryopreservation in 30% sucrose. Frozen sections were cut and
mounted on glass slides. For immunostaining, the following primary antibodies were used:
mouse anti-caspase 10, clone 16C5.1 (1:100; EMD Millipore, # MABC192); mouse anti-cleaved
caspase 9 (1:100; Cell Signaling, # 9509S); and guinea pig anti-histone H1t (1:500; kindly pro-
vided by Mary Ann Handel). After rinsing in PBST, the slides were incubated with appropriate
secondary antibodies diluted 1:200 in 1× PBS; Alexa 488-conjugated donkey anti-mouse IgG
(H+L) and Alexa 594-conjugated donkey anti-guinea pig IgG (H+L) (Jackson Immuno
Research, # 706-586-148). Slides were counter-stained with DAPI and mounted with Prolong
Gold (Thermo Fisher Scientific, # P36930). Slides were examined using a Nikon eclipse E800
microscope equipped with epifluorescence optics and the images were photographed with a
high-definition cooled color camera head DS-Fi1c. All images were processed with Adobe
Photoshop CS5 software.
To determine the number and percentage of late prophase I spermatocytes that were cas-
pase 9- or caspase 10-positive in WT and Ccna1-/- testes, testicular sections from three different
mice per genotype were examined and an average of 400 cells positive for H1t per animal,
which correspond to mid-pachytene to diplotene spermatocytes, were counted. From the H1t
positive cells, we then quantified the number of cells that were positive for caspase 9 or caspase
10. The quantification is presented as percentage ± standard deviation (SD). A statistical t test
was performed using a nonparametric Mann-Whitney signed-rank test to determine the dif-
ference between the genotypes, and the threshold of significance was set at 0.05 (GraphPad
Prism 5, GraphPad Software, Inc.).
Immunohistochemistry
Testes of mice at 17, 22 and 28 days of age were dissected and fixed with 4% paraformaldehyde
overnight at 4˚C. Fixed tissues were embedded in paraffin, sectioned at 5μm-thick and
mounted on slides. Immunohistochemistry was performed using a Vectastain ABC kit for
Rabbit IgG (# PK-6101, Vector Laboratories, Burlingame, CA) as described [13]. In brief, his-
tological sections were deparaffinized in histoclear, hydrated through an alcohol series fol-
lowed by a washing with distilled water. Antigen retrival was performed by boiling the slides
in a microwave for 10 min in 0.01M-citrate buffer, pH 6.0. Endogenous peroxidase was inacti-
vated by incubating the slides with 3% hydrogen peroxide for 30 minutes and then incubated
with blocking solution (2.5% goat serum) for 1 hr at room temperature. The sections were
then incubated with rabbit- anti Phospho-Akt Ser 473 (Cell Signaling # 4060) at 1:50 dilution
overnight at 4˚C. After three washes in 1XTBST (TBS with 0.1% TritonX-100), subsequent
steps were performed according to the manufacturer’s instructions. For visualization, the slides
were incubated with diaminobenzidine solution for 5 min, washed 3 times with distilled water
and counter stained with hematoxylin. Sections were dehydrated through an alcohol series
and mounted with permount mounting medium (Fisher Scientific # SP15-100). Slides were
examined on a Nikon microscope under brightfield optics and the images were processed
using Adobe Photoshop CS5 (Adobe, San Jose, CA).
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Results and discussion
Differential expression of apoptosis related genes in Ccna1-/-
spermatocytes
To identify the factors and pathways involved in the induction of apoptosis that occurs in late
prophase Ccna1-/- spermatocytes [13], we performed a qRT-PCR array analysis using the
Super Array (SA biosciences, # PAMM012Z), which measures the expression of 84 apoptosis-
related mouse genes. RNA samples were obtained from WT and Ccna1-/- testicular tubule sus-
pensions at PND 17, 22, and 28. These three time points were chosen based on previous
TUNEL assays showing that in the mutant testes, there were few apoptotic spermatocytes at
PND 17, that they increased significantly at PND 22, and that they were robustly detected at
PND 28 [15]. At PND 17, the cells in the first wave of spermatogenesis and would have reached
the pachytene-diplotene stage of meiosis. So theoretically, at this age both WT and mutant tes-
tes have a similar cellular composition. At PND 22 and PND 28, WT testes reached the sper-
matid stages and contain spermatogenic cells from spermatogonia to spermatids. In Ccna1-/-
mutant testes, spermatocytes are arrested at mid-diplotene stage and hence do not contain
spermatids. Although the cellular composition is different at PND 22 and PND 28 between the
WT and Ccna1-/- testes, the spermatids in the WT tubules are not TUNEL positive cells [15].
We therefore suggest that the presence of spermatids in the WT testes will not affect the
expression of apoptosis-related genes and detection of changes in expression in our array
analysis.
At PND 17, we found only two genes in the array, which were modulated in Ccna1-/-
tubules as compared to the WT control. Nod1 and Card6 were both down regulated by 3.03-
and 5.88-fold, respectively, and no genes were up regulated at this age (S1A Fig; S1 Table). At
PND 22, 39% (33 out of 84 genes) of the analyzed targets exhibited a change in expression
(S1B Fig; S1 Table): 19 were up regulated and 14 were down regulated. At PND 28, the number
of differentially expressed genes between WT and mutant was reduced to 28% (23 of 84
genes): 21 genes were up regulated and only two were down regulated (S1C Fig; S1 Table).
This trend of expression of pro-apoptotic genes was tightly correlated to the expression pat-
tern and function of Ccna1 protein during meiosis. That is, at PND 17, most of the spermato-
cytes are at late pachytene and diplotene stages and thus, are robustly expressing Ccna1. In the
absence of Ccna1, the defects produced by its depletion will have just started to manifest and
the induction to undergo apoptosis will have been initiated in only a few cells. However, by
PND 22, most of the late pachytene and diplotene spermatocytes will have initiated apoptosis
and exhibit TUNEL positive staining with all apoptotic pathways activated [15]. This observa-
tion is also consistent with our previous findings of no significant increase in TUNEL positive
cells in the Ccna1-/- testes at PND 17 but massive TUNEL-positive cells at PND 22 [15].
Although we previously found that the number of TUNEL-positive cells remains elevated
in the PND 28 mutant testes [15], the number of apoptosis-related gene expression changes
was reduced to 23, compared to the 33 genes observed in PND 22 (S1 Table). This difference is
likely due to the fact that the signaling to enter apoptosis was no longer needed and the
TUNEL-positive staining was due to non-clearance of apoptotic cells at this age. Interestingly,
at PND 28 there were many more up-regulated genes (21) relative to down-regulated genes
(2). Indeed, the majority of the up-regulated genes seen in PND 22 were still up-regulated at
PND 28, while most of the down-regulated genes seen at PND 22 were no longer repressed at
PND 28 (S1 Table). These results suggest that induction of apoptosis as a consequence of the
absence of Ccna1 is initiated by both up regulating pro-apoptotic genes, such as Bcl2l10,
Card6, Card10, Casp4, Fas and Tnf-α, and down-regulating anti-apoptotic genes, such as
Bcl2l1, Birc2, Trp63 and notably, Trp53. This observation reinforced the idea that although late
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pachytene and diplotene spermatocytes may have sensed the absence of Ccna1, apoptotic sig-
nals at PND 17 are not massively triggered. These observations further suggest that at later
stages of the apoptotic response, the up-regulation of pro-apoptotic genes might be more
important than decreased expression of anti-apoptotic genes.
To confirm and validate the data obtained with the array analysis, five genes were chosen
randomly (three for the intrinsic pathway and two for the extrinsic pathway specific) and their
mRNA levels examined by qRT-PCR using different sets of primers from the array analysis
and normalized to the housekeeping gene Arbp (which is different from actin and GAPDH
that were used in the Super Array) in WT and Ccna1-/- testes at PND 17, PND 22 and PND 28
(Fig 1A). A similar pattern of change in gene expression was observed as compared to the
array analysis.
In the array analysis, we noted that the expression of an anti-apoptotic gene, sphingosine
kinase 2 (Sphk2), was down regulated in Ccna1-/- testes at both PND 22 and 28, but not at
Fig 1. Sphk2 mediated down-regulation of p21 in Ccna1-/- mutant testes. A. Validation of relative mRNA expression of selected genes from the
array analysis, namely Bcl2l1, Fas, Tnf, Cradd and Sphk2, in WT (W) and Ccna1-/- (M) testicular tubule suspensions as determined by qRT-PCR. B
and C. The expression of Sphk2 and its possible target p21 was measured at both RNA (panel B) and protein (panel C) levels at indicated stages of
testes development i.e. PND 17, PND 22 and PND 28 respectively. Arbp was used as internal control for qRT-PCR and β-Actin served as loading
control in the immunoblot. Error bars represent standard deviation. * p< 0.05 and ** p< 0.01.
https://doi.org/10.1371/journal.pone.0173926.g001
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PND 17 (S1 Table). This is of interest, as Sphk2 is up regulated in several cancers and down
regulation of Sphk2 activates apoptotic proteins by several pathways including EGFR and
PI3K/AKT signaling [19, 20]. Moreover targeted siRNA knock down of Sphk2 has been
reported to result in the down-regulation of p21 in a p53-independent manner [21]. Interest-
ingly, our previous study showed that deletion of p53 could not rescue the apoptosis in
Ccna1-/- testes [15]. It is thus possible that the down-regulation of Sphk2 in the absence of
Ccna1 in our model induces a down-regulation of p21 and subsequent progression of apopto-
sis. Indeed, our qRT-PCR analysis revealed that both Sphk2 and p21 mRNA levels were
reduced in the mutant testes at PND 22 and PND 28, but not significantly at PND 17, relative
to WT control (Fig 1B). Immunoblot analysis further revealed a decrease in p21 protein levels
in Ccna1-/- testes compared to WT (Fig 1C). This suggests that Sphk2 could act as a regulator
of p21 expression and that loss of Ccna1 function results in a decrease in the expression of
Sphk2 and subsequently, p21. Such deregulation could contribute to impede the pro-survival
activity in Ccna1-/- spermatocytes, leading to the progression of apoptosis.
Intrinsic apoptotic signaling is activated earlier than extrinsic signaling in
Ccna1-deficient spermatocytes
Our results from the array analysis showed modulation of both pro- and anti-apoptotic genes
in Ccna1-deficient testes and importantly, we noted that these factors were from both intrinsic
(Bcl2l1, Bcl2l10,Bric2, Trp53 and Sphk2) and extrinsic (Tnf, Fas and Il10) pathways (S1 Table).
Bcl family members are known to initiate the intrinsic pathway by activating the initiator cas-
pase 9, while death domain receptors like Fas and Tnf execute the extrinsic apoptosis pathway
by recruiting caspases 8 and/or 10 as initiator molecules. In the array analysis, caspase 9 was
expressed at 1.95- and 1.68-fold higher levels in mutant testes as compared to the WT at PND
22 and PND 28, respectively (S1 Table). As we defined a cut-off of ±3 fold in our array data
analysis, caspase 9 was not highlighted in the table and no change in caspase 8 expression was
observed. Unfortunately, caspase 10 was not included in the Super Array.
To confirm that both intrinsic and extrinsic apoptotic pathways are involved in the apopto-
sis of Ccna1-/- spermatocytes, we examined the protein levels of the intrinsic pathway initiator
caspase 9 and the extrinsic pathway initiators caspase 8 and 10. Caspase 9 was undetectable
and caspase 10 levels were low in WT testis at PND 22 and PND 28, which correlated with our
previous observations of absence of TUNEL positive cells in WT cells at these time points [15].
Caspase 8 protein levels were unchanged in the testis lysates irrespective of the age and geno-
type of the animals (Fig 2A), which was consistent with the array data. In contrast, while no
significant changes were detected at PND 17, we observed an increase in the levels of both cas-
pase 9 and 10 in Ccna1-/- lysates at PND 22 and PND 28 (Fig 2A).
We then asked which apoptotic pathway is triggered first in the absence of Ccna1 in sper-
matocytes. To define the presence of intrinsic or extrinsic pathways at the single spermatocyte
level, we use immunofluorescence detection of the initiator caspases, caspase 9 (cleaved form)
and caspase 10 (total), along with detection of histone H1t to precisely identify late prophase I
spermatocytes. We first examined testes from PND 22 mice; however, both caspases were co-
expressed in most tubules and thus, identifying the temporal appearance of each pathway was
not possible at this age (data not shown). We therefore examined testes from PND 17 mice.
Mice of this age allowed us to detect the first diplotene cells that are undergoing apoptosis in
response to Ccna1 depletion. We found that the intrinsic pathway initiator caspase, caspase 9,
appeared in mid/late pachytene spermatocytes (as identified by being H1t-positive) at PND 17
and at this stage, there was little if any staining for caspase 10 (Fig 2B). Quantification of the
stained cells revealed that 12% ± 4.3 of late prophase I cells in Ccna1-/- testes were positive for
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caspase 9 as compared to 4% ± 2.1 observed in the WT control. No significant differences in
caspase 10 signals were observed between PND 17 WT and Ccna1-/- testes (Fig 2C). These
results indicate that activation of the intrinsic apoptotic pathway is an earlier event in response
to the absence of Ccna1 in spermatocytes, and precedes the extrinsic pathway function.
Identification of 14-3-3 proteins as Ccna1 interacting proteins
We next considered that there might be apoptotic-signaling molecules that actually interact
with and are inhibited by Ccna1 and which would be activated in its absence. To identify
Fig 2. Activation of the intrinsic apoptosis pathway occurs earlier than that of the extrinsic pathway in
Ccna1-deficient testes. A. Markers of intrinsic (caspase 9) and extrinsic (caspase 8 and 10) pathways were analyzed by
immunoblot analysis using testicular lysates from WT and Ccna1-deficient mice at PND 17, 22 and 28. β-Actin served as
loading control. B. Immunostaining of caspase 9 and 10 in both WT and mutant histological sections of PND 17 testes. H1t was
used as a marker for accurate classification of late prophase I spermatocytes (c-d, f-g). C. Quantification of late prophase I
spermatocytes that were positive for caspase 9 and 10 in WT and mutant testes at PND 17. Error bars represent standard
deviation. * p< 0.05.
https://doi.org/10.1371/journal.pone.0173926.g002
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Ccna1-interacting proteins in testis, we used a FLAG-pull down approach by expressing and
purifying FLAG-tagged Ccna1 from sf9 cells. Ccna1-interacting proteins were then purified
from lysates of purified WT pachytene spermatocytes using immobilized FLAG-Ccna1 beads
and FLAG-M2 beads as control. Bound proteins were eluted, and identified by LC-MS-MS as
described in materials and methods. With this approach, we identified a total of 30 candidate
proteins that bound specifically to Ccna1 but not to control beads (S2 Table).
The presence of the 14-3-3 proteins in this list was of particular interest as 14-3-3 proteins
are involved in various physiological processes including the inhibition of apoptosis [22, 23].
Mammalian 14-3-3- proteins consist of a family of 7 isoforms [24]. Our mass spectrometry
analysis identified two isoforms (z and θ) of 14-3-3 as binding partners of Ccna1. Three iso-
forms of 14-3-3 (β, θ and ε) have been reported to be expressed in testis and, interestingly, the
θ and ε isoforms were expressed in testicular germ cells whereas expression of 14-3-3 β is
restricted to Sertoli and Leydig cells [25]. Indeed, 14-3-3 θ is expressed in both pachytene sper-
matocytes and spermatids [25]. The expression pattern of z isoform and other isoforms in tes-
tis is unknown. Reciprocal immunoprecipitation using either anti-Ccna1 or anti-14-3-3
antibodies confirmed that Ccna1 indeed interacts with 14-3-3 proteins (Fig 3A). We next ana-
lyzed whether this interaction affects the expression levels of 14-3-3 by immunoblot analysis.
Depletion of Ccna1 did not affect the protein levels of 14-3-3 in mutant testicular lysates as
compared with WT (Fig 3B). While the antibody we had used recognizes all 14-3-3 isoforms,
the results should reflect the θ, z or ε isoforms due to their expression pattern in the testis [25]
and our mass spectrometry data.
Differences in the sub-cellular distribution of the 14-3-3 proteins in the
absence of Ccna1
The functions of 14-3-3 proteins vary depending on their subcellular distribution, their phos-
phorylation status, and the phosphorylation status of their interacting partners. In the nucleus,
they have been shown to induce the translocation of transcription factors such as FOXO from
the nucleus to the cytoplasm [26], thus inhibiting expression of pro-apoptotic genes like Bax,
Bad, and Bim [27, 28]. The 14-3-3 proteins can also function in the cytoplasm by sequestering
pro-apoptotic factors like Bax and Bad, and inhibiting their translocation to the mitochondria
[29, 30]. We therefore asked whether the sub-cellular localization of 14-3-3 proteins is altered
in the absence of Ccna1. Immunoblot analysis of nuclear and cytoplasmic fractions of testicu-
lar lysates (n = 6 mice, from 2 independent experiments) revealed a differential distribution of
14-3-3 proteins in PND28 testes but not in PND 17 testes. In WT testes, 72.4% ± 4.1 of 14-3-3
proteins were present in the cytoplasm and 27.6% ± 4.1 were found in the nuclear fraction (Fig
3C and 3D). In contrast, in Ccna1-/- testes, 94% ± 2.3 of 14-3-3 proteins were present in the
cytoplasm and only 6% ±2.3 were found in the nuclear fraction (Fig 3C and 3D). This change
was not due to variations in the protein levels, as the total 14-3-3 protein levels (nuclear and
cytoplasmic) remained the same between WT and mutant lysates at both PND 17 and PND 28
(Fig 3B and 3D). This result shows that in the absence of Ccna1, the subcellular localization of
14-3-3 was now mainly cytoplasmic rather than both cytoplasmic and nuclear. In addition, the
decreased levels of 14-3-3 observed in the nuclear fractions of Ccna1-/- spermatocytes suggest
that the inhibition of expression of pro-apoptotic genes like Bax and Bad could be affected in
the absence of Ccna1. In fact, our Super Array data showed that Bax and Bad mRNA levels
were>2 fold higher in PND 28 Ccna1-/- testes compared to WT control.
We next analyzed if the changes in the mRNA levels reflect the protein levels of Bax and
Bad. To this end, we measured the abundance of these proteins in WT and mutant testicular
lysates. We observed that the expression of both Bax and Bad was higher in mutant testes as
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Fig 3. Ccna1 interacts with the apoptotic inhibitor 14-3-3 and modulates its subcellular localization. A. Reciprocal immunoprecipitation
using either anti-14-3-3 (upper panel) or Ccna1 (lower panel) antibodies confirmed the interaction of Ccna1 with 14-3-3 in adult mouse testes. B.
The overall levels of 14-3-3 proteins did not change in mutant versus WT testes as analyzed by immunoblot analysis in PND 17 and PND 28
testicular lysates. β-Actin served as loading control. C. The sub-cellular distribution of 14-3-3 proteins was altered in Ccna1-deficient as compared
to WT testes at PND 17 and 28 as analyzed by immunoblot analysis using lysates from cytoplasmic (C) and nuclear fractions (N). Lamin B and
tubulin were used as markers for purity of nuclear and cytoplasmic fractions, respectively. β -Actin was used as the loading control. D.
Quantification of 14-3-3 levels in both cytoplasmic and nuclear fractions of PND 17 and PND 28 from two independent experiments. Error bars
represent standard deviation.
https://doi.org/10.1371/journal.pone.0173926.g003
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compared to wild type control at PND 22 and 28, whereas their levels did not change in PND
17 lysates (Fig 4A). Therefore, our results suggest that depletion of Ccna1 results in an incre-
ment of Bax and Bad levels in spermatocytes and further suggest that the changes in the subcel-
lular localization of 14-3-3 may be related to the expression of Bax and Bad in the mutant cells.
Akt phosphorylation is impaired in Ccna1 deficient spermatocytes
It is known that 14-3-3 exerts its cell survival function by interacting with and inhibiting the
pro-apoptotic function of several proteins, including Bad, FOXO, Raf1, and Death Associate
Fig 4. Apoptosis in Ccna1-deficient testes is characterized by elevated levels of Bax and Bad and decreased phosphorylation of
Akt. A. Protein levels of Bax and Bad are increased in PND 22 and 28 Ccna1-deficient testes as compared to WT controls as analyzed by
immunoblot analysis using lysates from WT and Ccna1-/- testes at different developmental ages. GAPDH served as the loading control. B.
Akt phosphorylation was decreased in the lysates Ccna1-/- testes versus WT at different developmental ages as analyzed by immunoblot
analysis. Total Akt levels were taken as the reference, and GAPDH served as the loading control. Numbers under each lane represent the
relative percentage of protein levels in mutant lysate compared to the WT control (100%) at indicated postnatal days. C.
Immunohistochemistry of phospho-Akt in WT and Ccna1-/- PND 17, PND 21 and PND 28 testes. The intensity of Akt phosphorylation in
Ccna1-/- spermatocytes was decreased as compared to WT control at PND 22 and PND 28. Original magnification x40.
https://doi.org/10.1371/journal.pone.0173926.g004
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Protein Kinase 2 (DAPK2) [31–34]. Phosphorylation of the above proteins is necessary for
their interaction with 14-3-3 and interestingly, all of them are reported as Akt substrates. Fur-
thermore, it has been shown that the activity of Akt fluctuates across the mitotic cell cycle and
mirrors the expression of cyclin A2 [35]. Moreover, cyclin A2-Cdk complexes can phosphory-
late and activate Akt [35]. It is thus possible that during normal meiosis, cyclin A1 mediates a
pro-survival signaling both by regulating and activating Akt and also by regulating 14-3-3
activities.
To examine this possibility, we determined the phosphorylation status of Akt, which is
known to be decreased either by depletion of the somatic A-type cyclin, cyclin A2, or CDK2 in
mitotic cells [35] and also favors cell proliferation. No differences in phospho-Akt (serine 473)
levels were observed at PND 17 (Fig 4B). However, Akt phosphorylation levels were reduced
by 20% in PND 22 Ccna1-/- lysates. At PND 28, this reduction reached 60% as compared to the
WT type controls, while the total levels of Akt remained unchanged at all time points. To con-
firm that changes in Akt phosphorylation in response to depletion of Ccna1 occur specifically
in the spermatocytes, we immunostained phospho-Akt (serine 473) in WT and Ccna1-/- PND
17, PND 22 and PND 28 testes. We observed that phospho-Akt signal localized principally in
spermatocytes at PND 17 WT and Ccna1-/- testes; and PND 22 and PND 28 WT testes (Fig
4C). However, and in agreement with the immunoblot results, PND 22 and PND 28 mutant
spermatocytes showed a decrease in phospho-Akt staining as compared to WT testes (Fig 4C).
Concomitantly, phospho-Akt levels remain unchanged between Ccna1-/- and WT control at
PND 17 and there are few if any phospho-Akt positive spermatids in WT PND 22 and PND 28
testes. This raised the possibility that Ccna1 might modulate pro-survival signaling through
Akt phosphorylation and interaction with 14-3-3 proteins.
Summary
We have provided evidence from array analysis that meiotically arrested Ccna1-/- spermato-
cytes initiate apoptosis via modulation of pro- and anti-apoptotic genes related to both the
intrinsic and extrinsic signaling pathways. We did not observe detectable changes in apopto-
sis-related gene expression between WT and mutant testes at the stage of differentiation when
Ccna1 is normally first expressed (PND 17). In contrast, pro-apoptotic genes are elevated at
subsequent developmental stages in the Ccna1-deficient testes. In addition, we found the
repression of anti-apoptotic genes at PND 22, which was later relieved at PND 28. We suggest
as a possible explanation for this observation that at later stages, repression of anti-apoptotic
genes might no longer be required to maintain the induction and progression of apoptosis in
mutant spermatocytes. Immunofluorescence analysis of the initiator caspases 9 and 10
revealed that apoptosis in Ccna1-/- spermatocytes was first initiated by the components of the
intrinsic pathway and later may be enhanced by both intrinsic and extrinsic components. We
further identified 14-3-3 proteins as an interacting partner of Ccna1 and showed that the
absence of Ccna1 affects the sub-cellular distribution of 14-3-3, but not the overall levels. This
distribution is important for driving cells toward survival or apoptosis, possibly by affecting
the expression of pro-apoptotic genes.
Our results also showed a decrease in the phosphorylation of Akt in the absence of Ccna1,
which could lead to a G2/M meiotic arrest and signaling to enter apoptosis. Our results suggest
that Ccna1 may also inhibit the apoptotic functions of several proteins, including Bax and Bad,
by recruiting 14-3-3 in the nucleus, and in its absence in nuclei, apoptosis signaling is activated
in the arrested spermatocytes. Finally, our data indicate that the intrinsic and extrinsic apopto-
tic signaling pathways, as well as 14-3-3 proteins, are important features of the apoptosis trig-
gered in the absence of a key meiotic regulator, Ccna1. Although the relevance of each
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apoptotic factor and pathway needs to be unraveled in future work, our results contribute to
the identification of the apoptotic response that results when meiosis is defective in male germ
cells.
Supporting information
S1 Fig. Differential expression of apoptotic factors in Ccna1-deficient testes relative to WT
control. Scatter plot analysis showed changes in apoptotic gene expression in mutant testes
compared to WT control. A; PND 17, B; PND 22, and C; PND 28 respectively. Blue dots repre-
sent down-regulated genes while red dots represent up-regulated genes. Grey dots represent
genes that underwent expression changes of less than 3-fold, which was chosen as the cut off
value.
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S1 Table. Apoptosis-related genes modulated in Ccna1-/- testes. All the genes on the array
are listed, along with their Accession Number. Genes undergoing at least 3-fold increase or
decrease in expression as compared to the WT control at both PND 22 and 28 are indicated in
bold font. The values presented are the fold change as compared to WT control. Up-regulated
genes are in red and down-regulated ones are marked in blue, respectively.
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S2 Table. Ccna1 interacting proteins identified by FLAG-pull down followed by
LC-MS-MS. Gene name and their Swiss Prot accession number were indicated. The extreme
right column showed the mascot score of each individual protein.
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